Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulationFan Liao, David M. Holtzman, Aimin Li et al.|Journal of Clinical Investigation|2018Cited by 186
Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy ModelAlexandra Litvinchuk, David M. Holtzman, Caroline Massad Francis et al.|Annals of Neurology|2021Cited by 80
Humanin variant <scp>P3S</scp> is associated with longevity in <i>APOE4</i> carriers and resists <i>APOE4</i>‐induced brain pathologyBrendan Miller, Pinchas Cohen, Su‐Jeong Kim et al.|Aging Cell|2024Cited by 16